drugset / Trial / NCT00183976

Pegylated Liposomal Doxorubicin (Doxil) With Rituximab in Relapsed AIDS-Related Non-Hodgkin's Lymphomas

NCT00183976 ↗

Phase 2 Terminated 15 enrolled University of Southern California
Non-randomizedSingle-groupOpen-labelTreatment

Summary

This study is for patients who have been treated before and either the treatment did not work or the lymphoma has come back.

Timeline

Start
2005-04
Primary completion
2005-09
Completion
2006-01

Outcome

Outcome not reported

Stopped (Enrollment): “Insufficient Accrual”

Drugs

EvaluationDrugModalityDoseRoute
Subject Doxorubicin Other / unclassified — —
Subject Rituximab Monoclonal antibody — —